Cargando…

Surface Trafficking of APP and BACE in Live Cells

Amyloid‐β (Aβ)‐peptide, the major constituent of the plaques that develop during Alzheimer's disease, is generated via the cleavage of Aβ precursor protein (APP) by β‐site APP‐cleaving enzyme (BACE). Using live‐cell imaging of APP and BACE labeled with pH‐sensitive proteins, we could detect the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauereiss, Anna, Welzel, Oliver, Jung, Jasmin, Grosse‐Holz, Simon, Lelental, Natalia, Lewczuk, Piotr, Wenzel, Eva M., Kornhuber, Johannes, Groemer, Teja W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680167/
https://www.ncbi.nlm.nih.gov/pubmed/25712587
http://dx.doi.org/10.1111/tra.12270
Descripción
Sumario:Amyloid‐β (Aβ)‐peptide, the major constituent of the plaques that develop during Alzheimer's disease, is generated via the cleavage of Aβ precursor protein (APP) by β‐site APP‐cleaving enzyme (BACE). Using live‐cell imaging of APP and BACE labeled with pH‐sensitive proteins, we could detect the release events of APP and BACE and their distinct kinetics. We provide kinetic evidence for the cleavage of APP by α‐secretase on the cellular surface after exocytosis. Furthermore, simultaneous dual‐color evanescent field illumination revealed that the two proteins are trafficked to the surface in separate compartments. Perturbing the membrane lipid composition resulted in a reduced frequency of exocytosis and affected BACE more strongly than APP. We propose that surface fusion frequency is a key factor regulating the aggregation of APP and BACE in the same membrane compartment and that this process can be modulated via pharmacological intervention. [Image: see text]